169 related articles for article (PubMed ID: 8539552)
1. Cost-benefit analysis of screening for toxoplasmosis during pregnancy.
Lappalainen M; Sintonen H; Koskiniemi M; Hedman K; Hiilesmaa V; Ammälä P; Teramo K; Koskela P
Scand J Infect Dis; 1995; 27(3):265-72. PubMed ID: 8539552
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of prevention strategies for congenital toxoplasmosis: a critical review of medico-economic studies].
Binquet C; Wallon M; Quantin C; Gadreau M; Peyron F
Rev Epidemiol Sante Publique; 2002 Oct; 50(5):475-87. PubMed ID: 12471340
[TBL] [Abstract][Full Text] [Related]
3. The program for antenatal screening of toxoplasmosis in Finland: a prospective cohort study.
Koskiniemi M; Lappalainen M; Koskela P; Hedman K; Ammälä P; Hiilesmaa V; Teramo K
Scand J Infect Dis Suppl; 1992; 84():70-4. PubMed ID: 1290079
[TBL] [Abstract][Full Text] [Related]
4. Prevention of congenital toxoplasmosis in Slovenia by serological screening of pregnant women.
Logar J; Petrovec M; Novak-Antolic Z; Premru-Srsen T; Cizman M; Arnez M; Kraut A
Scand J Infect Dis; 2002; 34(3):201-4. PubMed ID: 12030394
[TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of preventive programmes against congenital toxoplasmosis.
Stray-Pedersen B; Jenum P
Scand J Infect Dis Suppl; 1992; 84():86-96. PubMed ID: 1290083
[TBL] [Abstract][Full Text] [Related]
6. Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model.
Stillwaggon E; Carrier CS; Sautter M; McLeod R
PLoS Negl Trop Dis; 2011 Sep; 5(9):e1333. PubMed ID: 21980546
[TBL] [Abstract][Full Text] [Related]
7. Serological screening for toxoplasmosis in pregnancy in Slovenia.
Logar J; Novak-Antolic Z; Zore A
Scand J Infect Dis; 1995; 27(2):163-4. PubMed ID: 7660082
[TBL] [Abstract][Full Text] [Related]
8. Active control of congenital toxoplasmosis in the population.
Palicka P; Slabá H; Zitek K
Cent Eur J Public Health; 1998 Nov; 6(4):265-8. PubMed ID: 9919374
[TBL] [Abstract][Full Text] [Related]
9. [Toxoplasmosis in Poznan region, Poland 1990-2000].
Pawłowski ZS
Przegl Epidemiol; 2002; 56(3):409-17. PubMed ID: 12608090
[TBL] [Abstract][Full Text] [Related]
10. Congenital toxoplasmosis in Austria: Prenatal screening for prevention is cost-saving.
Prusa AR; Kasper DC; Sawers L; Walter E; Hayde M; Stillwaggon E
PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005648. PubMed ID: 28692640
[TBL] [Abstract][Full Text] [Related]
11. Screening and prevention of congenital toxoplasmosis: an effectiveness study in a population with a high infection rate.
Ricci M; Pentimalli H; Thaller R; Ravà L; Di Ciommo V
J Matern Fetal Neonatal Med; 2003 Dec; 14(6):398-403. PubMed ID: 15061319
[TBL] [Abstract][Full Text] [Related]
12. Prevention of congenital toxoplasmosis in Norway.
Stray-Pedersen B
Arch Pediatr; 2003 Feb; 10 Suppl 1():23-4. PubMed ID: 12802962
[No Abstract] [Full Text] [Related]
13. [Toxoplasmosis--epidemiology, clinical manifestation and infection in pregnant women].
Biesiada G; Kalinowska-Nowak A; Czepiel J; Mach T
Przegl Lek; 2006; 63(2):97-9. PubMed ID: 16969908
[TBL] [Abstract][Full Text] [Related]
14. Incidence of primary toxoplasma infections during pregnancy in southern Finland: a prospective cohort study.
Lappalainen M; Koskela P; Hedman K; Teramo K; Ammälä P; Hiilesmaa V; Koskiniemi M
Scand J Infect Dis; 1992; 24(1):97-104. PubMed ID: 1589732
[TBL] [Abstract][Full Text] [Related]
15. Screening for toxoplasmosis in pregnancy: what is the evidence of reducing a health problem?
Eskild A; Oxman A; Magnus P; Bjørndal A; Bakketeig LS
J Med Screen; 1996; 3(4):188-94. PubMed ID: 9041483
[TBL] [Abstract][Full Text] [Related]
16. Current situation regarding toxoplasmosis in Finland.
Lappalainen M
Arch Pediatr; 2003 Feb; 10 Suppl 1():19. PubMed ID: 12802959
[No Abstract] [Full Text] [Related]
17. Prevention of congenital toxoplasmosis in Szeged, Hungary.
Szénási Z; Ozsvár Z; Nagy E; Jeszenszky M; Szabó J; Gellén J; Végh M; Verhofstede C
Int J Epidemiol; 1997 Apr; 26(2):428-35. PubMed ID: 9169181
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Danish Congenital Toxoplasmosis Study Group .
Lebech M; Andersen O; Christensen NC; Hertel J; Nielsen HE; Peitersen B; Rechnitzer C; Larsen SO; Nørgaard-Pedersen B; Petersen E
Lancet; 1999 May; 353(9167):1834-7. PubMed ID: 10359408
[TBL] [Abstract][Full Text] [Related]
19. Congenital toxoplasmosis: prevention, screening and treatment.
Holliman RE
J Hosp Infect; 1995 Jun; 30 Suppl():179-90. PubMed ID: 7560949
[TBL] [Abstract][Full Text] [Related]
20. Congenital toxoplasmosis: is screening desirable?
Foulon W
Scand J Infect Dis Suppl; 1992; 84():11-7. PubMed ID: 1290068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
